Target intelligence / Profile preview

Plasma proteins and membrane proteins

Molecular classification
Other
01

Overview

The term Plasma proteins and membrane proteins refers to two vast and distinct categories of proteins rather than a single therapeutic target. Plasma proteins, primarily synthesized in the liver, include albumin, globulins, and fibrinogen, which are essential for maintaining oncotic pressure, blood coagulation, and the transport of lipids, hormones, and drugs (StatPearls, 2023). Membrane proteins are diverse molecules embedded in or associated with the lipid bilayer of cells, serving as receptors, ion channels, and transporters that mediate cellular signaling and transport (Nature Education, 2014). While many individual proteins within these groups are critical drug targets or influence drug pharmacokinetics, the collective term is too broad for specific therapeutic classification. In drug development, understanding the interaction between a lead compound and plasma proteins is vital for predicting its distribution and free fraction in the blood (PubMed, 2021). Consequently, this entry is considered incorrect as a specific target because it encompasses thousands of proteins with unrelated functions and structures.

Other names
Blood proteinsSerum proteinsCell surface proteinsIntegral membrane proteinsPeripheral membrane proteinsTransmembrane proteins
02

Mechanism of action

As a broad category rather than a single target, drugs interact with specific members of these groups through diverse mechanisms, including reversible binding to transport proteins like albumin or the modulation of specific membrane-bound receptors and ion channels.

03

Biological functions

TransportSignal transductionImmune responseCell adhesionEnzymatic activityOsmotic pressure regulation
04

Disease associations

CancerInflammationCardiovascular diseaseInfectionMetabolic disorder
05

Safety considerations

Drug-drug interactions due to displacement from protein binding sitesAltered drug distribution in patients with hypoalbuminemiaNon-specific toxicityTherapeutic index narrowness for highly protein-bound drugs
06

Interacting drugs

Warfarin

4 more in the full profile.

07

Biomarkers

Serum albuminC-reactive proteinHaptoglobinSpecific membrane antigens (e.g., HER2, CD20)

Beyond the preview

Go deeper on Plasma proteins and membrane proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma proteins and membrane proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call